Narcolepsy Therapeutics Market Size, Trends, Analysis, and Outlook By Treatment (Narcolepsy with cataplexy, Narcolepsy without cataplexy, Secondary narcolepsy), By Product (Central nervous system stimulants, Sodium Oxybate, Selective serotonin reuptake inhibitor, Tricyclic antidepressants, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Narcolepsy Therapeutics market size is poised to register 8.51% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Narcolepsy Therapeutics market across By Treatment (Narcolepsy with cataplexy, Narcolepsy without cataplexy, Secondary narcolepsy), By Product (Central nervous system stimulants, Sodium Oxybate, Selective serotonin reuptake inhibitor, Tricyclic antidepressants, Others).
The Narcolepsy Therapeutics market is experiencing significant growth attributed to the increasing awareness about narcolepsy, advancements in diagnosis and treatment, and expanding research efforts focused on understanding the underlying mechanisms of the disorder. Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, and hallucinations, resulting from the dysregulation of sleep-wake cycles and neurotransmitter imbalances in the brain. Key drivers of market growth include the growing prevalence of narcolepsy, rising demand for symptom management therapies, and the development of novel pharmacological agents targeting orexin receptors, histamine receptors, and gamma-aminobutyric acid (GABA) receptors. Additionally, the availability of diagnostic tools, such as polysomnography and multiple sleep latency tests, is facilitating early diagnosis and intervention, improving clinical outcomes for narcolepsy patients. Moreover, the increasing adoption of stimulant medications, wakefulness-promoting agents, and antidepressants in narcolepsy management is driving market expansion. Furthermore, research into the genetic, environmental, and immunological factors contributing to narcolepsy susceptibility is driving drug discovery efforts and personalized treatment approaches tailored to individual patient profiles.
Narcolepsy Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Narcolepsy Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Narcolepsy Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Narcolepsy Therapeutics industry.
Key market trends defining the global Narcolepsy Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Narcolepsy Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Narcolepsy Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Narcolepsy Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Narcolepsy Therapeutics industry
Leading Narcolepsy Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Narcolepsy Therapeutics companies.
Narcolepsy Therapeutics Market Study- Strategic Analysis Review
The Narcolepsy Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Narcolepsy Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Narcolepsy Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Narcolepsy Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Narcolepsy Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Narcolepsy Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Narcolepsy Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Narcolepsy Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Narcolepsy Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Narcolepsy Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Narcolepsy Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Narcolepsy Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Narcolepsy Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Narcolepsy Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Narcolepsy Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Narcolepsy Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Narcolepsy Therapeutics.
Narcolepsy Therapeutics Market Company Profiles
The global Narcolepsy Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Avadel Pharmaceuticals, Axsome Therapeutics Inc, Harmony Biosciences, Jazz Pharmaceuticals PLC, Ligand Pharmaceuticals Inc, Novartis AG, Shionogi Inc, Takeda Pharmaceutical Company, Teva Pharmaceuticals Industries Ltd, XWPharma Ltd
Recent Narcolepsy Therapeutics Market Developments
The global Narcolepsy Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Narcolepsy Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Treatment
Narcolepsy with cataplexy
Narcolepsy without cataplexy
Secondary narcolepsy
By Product
Central nervous system stimulants
Sodium Oxybate
Selective serotonin reuptake inhibitor
Tricyclic antidepressants
Others
Geographical Segmentation:
Avadel Pharmaceuticals
Axsome Therapeutics Inc
Harmony Biosciences
Jazz Pharmaceuticals PLC
Ligand Pharmaceuticals Inc
Novartis AG
Shionogi Inc
Takeda Pharmaceutical Company
Teva Pharmaceuticals Industries Ltd
XWPharma Ltd
Formats Available: Excel, PDF, and PPT
The Narcolepsy Therapeutics market is experiencing significant growth attributed to the increasing awareness about narcolepsy, advancements in diagnosis and treatment, and expanding research efforts focused on understanding the underlying mechanisms of the disorder. Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, and hallucinations, resulting from the dysregulation of sleep-wake cycles and neurotransmitter imbalances in the brain. Key drivers of market growth include the growing prevalence of narcolepsy, rising demand for symptom management therapies, and the development of novel pharmacological agents targeting orexin receptors, histamine receptors, and gamma-aminobutyric acid (GABA) receptors. Additionally, the availability of diagnostic tools, such as polysomnography and multiple sleep latency tests, is facilitating early diagnosis and intervention, improving clinical outcomes for narcolepsy patients. Moreover, the increasing adoption of stimulant medications, wakefulness-promoting agents, and antidepressants in narcolepsy management is driving market expansion. Furthermore, research into the genetic, environmental, and immunological factors contributing to narcolepsy susceptibility is driving drug discovery efforts and personalized treatment approaches tailored to individual patient profiles.
Narcolepsy Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Narcolepsy Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Narcolepsy Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Narcolepsy Therapeutics industry.
Key market trends defining the global Narcolepsy Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Narcolepsy Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Narcolepsy Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Narcolepsy Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Narcolepsy Therapeutics industry
Leading Narcolepsy Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Narcolepsy Therapeutics companies.
Narcolepsy Therapeutics Market Study- Strategic Analysis Review
The Narcolepsy Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Narcolepsy Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Narcolepsy Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Narcolepsy Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Narcolepsy Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Narcolepsy Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Narcolepsy Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Narcolepsy Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Narcolepsy Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Narcolepsy Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Narcolepsy Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Narcolepsy Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Narcolepsy Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Narcolepsy Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Narcolepsy Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Narcolepsy Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Narcolepsy Therapeutics.
Narcolepsy Therapeutics Market Company Profiles
The global Narcolepsy Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Avadel Pharmaceuticals, Axsome Therapeutics Inc, Harmony Biosciences, Jazz Pharmaceuticals PLC, Ligand Pharmaceuticals Inc, Novartis AG, Shionogi Inc, Takeda Pharmaceutical Company, Teva Pharmaceuticals Industries Ltd, XWPharma Ltd
Recent Narcolepsy Therapeutics Market Developments
The global Narcolepsy Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Narcolepsy Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Treatment
Narcolepsy with cataplexy
Narcolepsy without cataplexy
Secondary narcolepsy
By Product
Central nervous system stimulants
Sodium Oxybate
Selective serotonin reuptake inhibitor
Tricyclic antidepressants
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Avadel Pharmaceuticals
Axsome Therapeutics Inc
Harmony Biosciences
Jazz Pharmaceuticals PLC
Ligand Pharmaceuticals Inc
Novartis AG
Shionogi Inc
Takeda Pharmaceutical Company
Teva Pharmaceuticals Industries Ltd
XWPharma Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Narcolepsy Therapeutics Market Overview and Key Findings, 2024
1.2 Narcolepsy Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Narcolepsy Therapeutics Market Growth Opportunities to 2030
1.4 Key Narcolepsy Therapeutics Market Trends and Challenges
1.4.1 Narcolepsy Therapeutics Market Drivers and Trends
1.4.2 Narcolepsy Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Narcolepsy Therapeutics Companies
2. NARCOLEPSY THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Narcolepsy Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Narcolepsy Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NARCOLEPSY THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NARCOLEPSY THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Treatment
Narcolepsy with cataplexy
Narcolepsy without cataplexy
Secondary narcolepsy
By Product
Central nervous system stimulants
Sodium Oxybate
Selective serotonin reuptake inhibitor
Tricyclic antidepressants
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Narcolepsy Therapeutics Market, 2025
5.2 Asia Pacific Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Narcolepsy Therapeutics Market, 2025
5.5 Europe Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Narcolepsy Therapeutics Market, 2025
5.8 North America Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Narcolepsy Therapeutics Market, 2025
5.11 South America Pacific Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Narcolepsy Therapeutics Market, 2025
5.14 Middle East Africa Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Narcolepsy Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Narcolepsy Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Narcolepsy Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Narcolepsy Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Narcolepsy Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Narcolepsy Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Narcolepsy Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Narcolepsy Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Narcolepsy Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Narcolepsy Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Narcolepsy Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Narcolepsy Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Narcolepsy Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Narcolepsy Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Narcolepsy Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Narcolepsy Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Narcolepsy Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Narcolepsy Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Narcolepsy Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Narcolepsy Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Narcolepsy Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Narcolepsy Therapeutics Industry Drivers and Opportunities
7. NARCOLEPSY THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NARCOLEPSY THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Narcolepsy Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Avadel Pharmaceuticals
Axsome Therapeutics Inc
Harmony Biosciences
Jazz Pharmaceuticals PLC
Ligand Pharmaceuticals Inc
Novartis AG
Shionogi Inc
Takeda Pharmaceutical Company
Teva Pharmaceuticals Industries Ltd
XWPharma Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Narcolepsy Therapeutics Market Overview and Key Findings, 2024
1.2 Narcolepsy Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Narcolepsy Therapeutics Market Growth Opportunities to 2030
1.4 Key Narcolepsy Therapeutics Market Trends and Challenges
1.4.1 Narcolepsy Therapeutics Market Drivers and Trends
1.4.2 Narcolepsy Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Narcolepsy Therapeutics Companies
2. NARCOLEPSY THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Narcolepsy Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Narcolepsy Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NARCOLEPSY THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NARCOLEPSY THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Treatment
Narcolepsy with cataplexy
Narcolepsy without cataplexy
Secondary narcolepsy
By Product
Central nervous system stimulants
Sodium Oxybate
Selective serotonin reuptake inhibitor
Tricyclic antidepressants
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Narcolepsy Therapeutics Market, 2025
5.2 Asia Pacific Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Narcolepsy Therapeutics Market, 2025
5.5 Europe Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Narcolepsy Therapeutics Market, 2025
5.8 North America Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Narcolepsy Therapeutics Market, 2025
5.11 South America Pacific Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Narcolepsy Therapeutics Market, 2025
5.14 Middle East Africa Narcolepsy Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Narcolepsy Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Narcolepsy Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Narcolepsy Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Narcolepsy Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Narcolepsy Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Narcolepsy Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Narcolepsy Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Narcolepsy Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Narcolepsy Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Narcolepsy Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Narcolepsy Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Narcolepsy Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Narcolepsy Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Narcolepsy Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Narcolepsy Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Narcolepsy Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Narcolepsy Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Narcolepsy Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Narcolepsy Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Narcolepsy Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Narcolepsy Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Narcolepsy Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Narcolepsy Therapeutics Industry Drivers and Opportunities
7. NARCOLEPSY THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NARCOLEPSY THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Narcolepsy Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Avadel Pharmaceuticals
Axsome Therapeutics Inc
Harmony Biosciences
Jazz Pharmaceuticals PLC
Ligand Pharmaceuticals Inc
Novartis AG
Shionogi Inc
Takeda Pharmaceutical Company
Teva Pharmaceuticals Industries Ltd
XWPharma Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
